US Patent Issued to Takeda Pharmaceuticals U.S.A. on May 13 for "Oligonucleotides for the treatment of nucleotide repeat expansion disorders associated with MSH3 activity" (Massachusetts Inventors)

ALEXANDRIA, Va., June 12 -- United States Patent no. 12,297,432, issued on May 13, was assigned to Takeda Pharmaceuticals U.S.A. Inc. (Cambridge, Mass.).

"Oligonucleotides for the treatment of nucleotide repeat expansion disorders associated with MSH3 activity" was invented by Nessan Anthony Bermingham (Cambridge, Mass.), Brian R. Bettencourt (Cambridge, Mass.) and Pei Ge (Cambridge, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure features useful compositions and methods to treat nucleotide repeat expansion disorders, e.g., in a subject in need thereof. In some aspects, the compositions and methods described herein are useful in the treatment of disorders associated with MSH3 acti...